Hims & Hers Health’s (HIMS) Underperform Rating Reiterated at Bank of America
Bank of America restated their underperform rating on shares of Hims & Hers Health (NYSE:HIMS – Free Report) in a research note published on Thursday morning,Benzinga reports. The brokerage currently has a $21.00 price objective on the stock. A number of other research firms also recently weighed in on HIMS. TD Cowen restated a “buy” […]
Bank of America restated their underperform rating on shares of Hims & Hers Health (NYSE:HIMS – Free Report) in a research note published on Thursday morning,Benzinga reports. The brokerage currently has a $21.00 price objective on the stock. A number of other research firms also recently weighed in on HIMS. TD Cowen restated a “buy” […]
